Lilly obesity-pill trial results find a warmer reception on Wall Street this time around
Up next
Author


Pharmaceutical giant Eli Lilly said it will now move “with urgency” toward getting regulatory approval for orforglipron.

You May Also Like
In Norfolk Southern board battle, proxy adviser Egan-Jones throws weight behind activist Ancora

In Norfolk Southern board battle, proxy adviser Egan-Jones throws weight behind activist Ancora

Egan-Jones has joined fellow proxy advisers Institutional Shareholder Services and Glass Lewis…
The U.S. economy is getting closer to a recession. What is the Fed waiting for? 

The U.S. economy is getting closer to a recession. What is the Fed waiting for? 

The Fed should cut rates by 0.5% before the Jackson Hole meeting…
A rising U.S. dollar could cause trouble for stock-market bulls

A rising U.S. dollar could cause trouble for stock-market bulls

Stock-market investors will want to keep a nervous eye on the U.S.…

Bond yields rise after Senate Democrats appear poised to back funding bill

Bond yields rose on Friday, responding to the general risk-on environment on…